While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), ...

iOS 26.1 recently introduced a big change for how you turn off alarms and timers, replacing the ‘Stop’ button with a new ‘Slide to stop’ action. Here’s how to get the button back. Apple lets you ...

Lando Norris winning the F1 drivers' championship in Abu Dhabi Clive Rose / Getty Images Just a day after winning his first Formula One world championship, Lando Norris faced a big decision for the ...

ST. PAUL, MN / ACCESS Newswire / December 4, 2025 / Odyssey Transfer and Trust Company (“Odyssey” or the “Company“), a leading North American transfer agent and trust company that is scaling rapidly ...

Dec 1 (Reuters) - The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity, conditionally recommending them as part of long-term treatment for the ...

Artificial intelligence is changing how people shop, with consumers using AI tools, like Google's Gemini and Open AI's Chat GPT, to research items and find the best deals. Artificial intelligence is ...

Globally, more than 1 billion people currently live with obesity. The World Health Organization on Monday released new guidance on GLP-1 medications for adults with obesity, recommending their ...

Erielle Sudario is a Collider News and Feature Author from Australia and has worked in the journalism industry since 2018. She has a passion for entertainment and pop culture news and has interviewed ...

A new study hints that pregnant people who have previously taken drugs like Ozempic may face a higher risk of certain poor pregnancy outcomes. But more studies are needed to understand the finding.

– Single subcutaneous dose of ADX-038 achieved near-complete alternative pathway suppression for 6 months, supporting potent and selective CFB silencing – – Phase 2 studies are ongoing to assess the ...

Emcor is one of the latest entrants to the S&P 500 index. The company's stock has handily outperformed the S&P index in recent years. Robust demand from artificial intelligence (AI) data centers is ...

The obesity rate in the U.S. has seen a marked decline over the last three years, as the share of Americans who report using GLP-1 agonists for weight loss skyrockets, according to data from Gallup.